The management and degree of severity of neurological manifestations during the active
phase of COVID-19 and beyond is currently a challenge. Especially because of the indirect …

In December 2019, in Wuhan (China), a highly pathogenic coronavirus, named SARS-CoV-
2, dramatically emerged. This new virus, which causes severe pneumonia, is rapidly …

Over the 4 last years, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
determined the diffusion of the coronavirus disease 2019 (COVID-19) global outbreak [1] …

According to the British guidelines, the post COVID-19 syndrome (PCS) is defined as a
constellation of symptoms which develops following a severe acute respiratory syndrome …

Introduction The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect
multiple organs. Reports of persistent or newly emergent symptoms, including those related …

Purpose Numerous studies suggest that infection with coronavirus SARS-CoV-2, which
causes acute respiratory distress syndrome and COVID-19 illness, can lead to changes in …

We read with great interest the article by Lavienraj Premraj et al. recently published in your
journal [1]. This study reported the results of a systematic review and meta-analysis …

Evolving data show a variable expression of clinical neurological manifestations in patients
suffering with coronavirus disease 2019 (COVID-19) from early disease onset. The most …

The post COVID-19 syndrome (PCS) is an emerging phenomenon worldwide with
enormous socioeconomic impact. While many patients describe neuropsychiatric deficits …

Background: Albeit primarily a disease of respiratory tract, the 2019 coronavirus infectious
disease (COVID-19) has been found to have causal association with a plethora of …